APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sodium Valproate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sodium Valproate Market Outlook and Growth Opportunities 2026

20 December 2025198 pages

Choose your research edition.

Industry ResearchSodium Valproate Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sodium Valproate Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Sodium Valproate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sodium Valproate Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Sodium Valproate Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Sodium Valproate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sodium Valproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sodium Valproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sodium Valproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sodium Valproate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sodium Valproate market include Sanofi, Fresenius Kabi, AbbVie, Zentiva, Wockhardt, Hikma Farmaceutica, Desitin Pharmaceuticals and Athenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sodium Valproate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sodium Valproate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sodium Valproate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sodium Valproate market size, projected growth trends, production technologies, key applications, and end-use industries.

Sodium Valproate Segment by Company

Sanofi

Fresenius Kabi

AbbVie

Zentiva

Wockhardt

Hikma Farmaceutica

Desitin Pharmaceuticals

Athenex

Sodium Valproate Segment by Type

Tablet

Liquid

Injection

Sodium Valproate Segment by Application

Epilepsy

Migraines

Others

Sodium Valproate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Sodium Valproate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sodium Valproate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sodium Valproate significant trends, drivers, influence factors in global and regions.

6. To analyze Sodium Valproate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Valproate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sodium Valproate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Valproate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sodium Valproate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sodium Valproate industry.

Chapter 3: Detailed analysis of Sodium Valproate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sodium Valproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sodium Valproate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sodium Valproate Industry Trends Table 2. Sodium Valproate Industry Drivers Table 3. Sodium Valproate Industry Opportunities and Challenges Table 4. Sodium Valproate Industry Restraints Table 5. Global Sodium Valproate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sodium Valproate Revenue Share by Company (2021-2026) Table 7. Global Sodium Valproate Sales Volume by Company (W Tons) & (2021-2026) Table 8. Global Sodium Valproate Sales Volume Share by Company (2021-2026) Table 9. Global Sodium Valproate Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Sodium Valproate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sodium Valproate Key Company Manufacturing Base & Headquarters Table 12. Global Sodium Valproate Company, Product Type & Application Table 13. Global Sodium Valproate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sodium Valproate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Liquid Table 19. Significant Companies of Injection Table 20. Global Sodium Valproate Sales Volume by Type 2021 VS 2025 VS 2032 (W Tons) Table 21. Global Sodium Valproate Sales Volume by Type (2021-2026) & (W Tons) Table 22. Global Sodium Valproate Sales Volume by Type (2027-2032) & (W Tons) Table 23. Global Sodium Valproate Sales Volume Share by Type (2021-2026) Table 24. Global Sodium Valproate Sales Volume Share by Type (2027-2032) Table 25. Global Sodium Valproate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sodium Valproate Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Sodium Valproate Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Sodium Valproate Sales Value Share by Type (2021-2026) Table 29. Global Sodium Valproate Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Epilepsy Table 31. Significant Companies of Migraines Table 32. Significant Companies of Others Table 33. Global Sodium Valproate Sales Volume by Application 2021 VS 2025 VS 2032 (W Tons) Table 34. Global Sodium Valproate Sales Volume by Application (2021-2026) & (W Tons) Table 35. Global Sodium Valproate Sales Volume by Application (2027-2032) & (W Tons) Table 36. Global Sodium Valproate Sales Volume Share by Application (2021-2026) Table 37. Global Sodium Valproate Sales Volume Share by Application (2027-2032) Table 38. Global Sodium Valproate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Sodium Valproate Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Sodium Valproate Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Sodium Valproate Sales Value Share by Application (2021-2026) Table 42. Global Sodium Valproate Sales Value Share by Application (2027-2032) Table 43. Global Sodium Valproate Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 44. Global Sodium Valproate Sales by Region (2021-2026) & (W Tons) Table 45. Global Sodium Valproate Sales Market Share by Region (2021-2026) Table 46. Global Sodium Valproate Sales by Region (2027-2032) & (W Tons) Table 47. Global Sodium Valproate Sales Market Share by Region (2027-2032) Table 48. Global Sodium Valproate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Sodium Valproate Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Sodium Valproate Sales Value Share by Region (2021-2026) Table 51. Global Sodium Valproate Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Sodium Valproate Sales Value Share by Region (2027-2032) Table 53. Global Sodium Valproate Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Sodium Valproate Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Sodium Valproate Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Table 56. Global Sodium Valproate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Sodium Valproate Sales by Country (2021-2026) & (W Tons) Table 58. Global Sodium Valproate Sales Market Share by Country (2021-2026) Table 59. Global Sodium Valproate Sales by Country (2027-2032) & (W Tons) Table 60. Global Sodium Valproate Sales Market Share by Country (2027-2032) Table 61. Global Sodium Valproate Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Sodium Valproate Sales Value Market Share by Country (2021-2026) Table 63. Global Sodium Valproate Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Sodium Valproate Sales Value Market Share by Country (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Sodium Valproate Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Sanofi Sodium Valproate Product Portfolio Table 69. Sanofi Recent Development Table 70. Fresenius Kabi Company Information Table 71. Fresenius Kabi Business Overview Table 72. Fresenius Kabi Sodium Valproate Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Fresenius Kabi Sodium Valproate Product Portfolio Table 74. Fresenius Kabi Recent Development Table 75. AbbVie Company Information Table 76. AbbVie Business Overview Table 77. AbbVie Sodium Valproate Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. AbbVie Sodium Valproate Product Portfolio Table 79. AbbVie Recent Development Table 80. Zentiva Company Information Table 81. Zentiva Business Overview Table 82. Zentiva Sodium Valproate Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Zentiva Sodium Valproate Product Portfolio Table 84. Zentiva Recent Development Table 85. Wockhardt Company Information Table 86. Wockhardt Business Overview Table 87. Wockhardt Sodium Valproate Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Wockhardt Sodium Valproate Product Portfolio Table 89. Wockhardt Recent Development Table 90. Hikma Farmaceutica Company Information Table 91. Hikma Farmaceutica Business Overview Table 92. Hikma Farmaceutica Sodium Valproate Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Hikma Farmaceutica Sodium Valproate Product Portfolio Table 94. Hikma Farmaceutica Recent Development Table 95. Desitin Pharmaceuticals Company Information Table 96. Desitin Pharmaceuticals Business Overview Table 97. Desitin Pharmaceuticals Sodium Valproate Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Desitin Pharmaceuticals Sodium Valproate Product Portfolio Table 99. Desitin Pharmaceuticals Recent Development Table 100. Athenex Company Information Table 101. Athenex Business Overview Table 102. Athenex Sodium Valproate Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Athenex Sodium Valproate Product Portfolio Table 104. Athenex Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Sodium Valproate Distributors List Table 108. Sodium Valproate Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Sodium Valproate Product Image Figure 2. Global Sodium Valproate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sodium Valproate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sodium Valproate Sales (2021-2032) & (W Tons) Figure 5. Global Sodium Valproate Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Sodium Valproate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Liquid Image Figure 11. Injection Image Figure 12. Global Sodium Valproate Sales Volume by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 13. Global Sodium Valproate Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Sodium Valproate Sales Volume Share by Type (2021-2032) Figure 15. Global Sodium Valproate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Sodium Valproate Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Sodium Valproate Sales Value Share by Type (2021-2032) Figure 18. Epilepsy Image Figure 19. Migraines Image Figure 20. Others Image Figure 21. Global Sodium Valproate Sales Volume by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 22. Global Sodium Valproate Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Sodium Valproate Sales Volume Share by Application (2021-2032) Figure 24. Global Sodium Valproate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Sodium Valproate Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Sodium Valproate Sales Value Share by Application (2021-2032) Figure 27. Global Sodium Valproate Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 28. Global Sodium Valproate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Sodium Valproate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Sodium Valproate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Sodium Valproate Sales Value (2021-2032) & (US$ Million) Figure 32. North America Sodium Valproate Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Sodium Valproate Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Sodium Valproate Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Sodium Valproate Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Sodium Valproate Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Sodium Valproate Sales Value (2021-2032) & (US$ Million) Figure 38. South America Sodium Valproate Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Sodium Valproate Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Sodium Valproate Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Sodium Valproate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Sodium Valproate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Sodium Valproate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Sodium Valproate Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Sodium Valproate Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Liquid
  • Injection
Applications
  • Epilepsy
  • Migraines
  • Others
Companies covered
  • Sanofi
  • Fresenius Kabi
  • AbbVie
  • Zentiva
  • Wockhardt
  • Hikma Farmaceutica
  • Desitin Pharmaceuticals
  • Athenex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sodium Valproate Sales Value (2021-2032)
  4. 1.2.2 Global Sodium Valproate Sales Volume (2021-2032)
  5. 1.2.3 Global Sodium Valproate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sodium Valproate Market Dynamics
  1. 2.1 Sodium Valproate Industry Trends
  2. 2.2 Sodium Valproate Industry Drivers
  3. 2.3 Sodium Valproate Industry Opportunities and Challenges
  4. 2.4 Sodium Valproate Industry Restraints
3 Sodium Valproate Market by Company
  1. 3.1 Global Sodium Valproate Company Revenue Ranking in 2025
  2. 3.2 Global Sodium Valproate Revenue by Company (2021-2026)
  3. 3.3 Global Sodium Valproate Sales Volume by Company (2021-2026)
  4. 3.4 Global Sodium Valproate Average Price by Company (2021-2026)
  5. 3.5 Global Sodium Valproate Company Ranking (2024-2026)
  6. 3.6 Global Sodium Valproate Company Manufacturing Base and Headquarters
  7. 3.7 Global Sodium Valproate Company Product Type and Application
  8. 3.8 Global Sodium Valproate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sodium Valproate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sodium Valproate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sodium Valproate Market by Type
  1. 4.1 Sodium Valproate Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Liquid
  4. 4.1.3 Injection
  5. 4.2 Global Sodium Valproate Sales Volume by Type
  6. 4.2.1 Global Sodium Valproate Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sodium Valproate Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Sodium Valproate Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Sodium Valproate Sales Value by Type
  10. 4.3.1 Global Sodium Valproate Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Sodium Valproate Sales Value by Type (2021-2032)
  12. 4.3.3 Global Sodium Valproate Sales Value Share by Type (2021-2032)
5 Sodium Valproate Market by Application
  1. 5.1 Sodium Valproate Application Introduction
  2. 5.1.1 Epilepsy
  3. 5.1.2 Migraines
  4. 5.1.3 Others
  5. 5.2 Global Sodium Valproate Sales Volume by Application
  6. 5.2.1 Global Sodium Valproate Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sodium Valproate Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sodium Valproate Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sodium Valproate Sales Value by Application
  10. 5.3.1 Global Sodium Valproate Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sodium Valproate Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sodium Valproate Sales Value Share by Application (2021-2032)
6 Sodium Valproate Regional Sales and Value Analysis
  1. 6.1 Global Sodium Valproate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sodium Valproate Sales by Region (2021-2032)
  3. 6.2.1 Global Sodium Valproate Sales by Region: 2021-2026
  4. 6.2.2 Global Sodium Valproate Sales by Region (2027-2032)
  5. 6.3 Global Sodium Valproate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sodium Valproate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sodium Valproate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sodium Valproate Sales Value by Region (2027-2032)
  9. 6.5 Global Sodium Valproate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sodium Valproate Sales Value (2021-2032)
  12. 6.6.2 North America Sodium Valproate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sodium Valproate Sales Value (2021-2032)
  15. 6.7.2 Europe Sodium Valproate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sodium Valproate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sodium Valproate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sodium Valproate Sales Value (2021-2032)
  21. 6.9.2 South America Sodium Valproate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sodium Valproate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sodium Valproate Sales Value Share by Country, 2025 VS 2032
7 Sodium Valproate Country-level Sales and Value Analysis
  1. 7.1 Global Sodium Valproate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sodium Valproate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sodium Valproate Sales by Country (2021-2032)
  4. 7.3.1 Global Sodium Valproate Sales by Country (2021-2026)
  5. 7.3.2 Global Sodium Valproate Sales by Country (2027-2032)
  6. 7.4 Global Sodium Valproate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sodium Valproate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sodium Valproate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sodium Valproate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sodium Valproate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sodium Valproate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sodium Valproate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sodium Valproate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sodium Valproate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sodium Valproate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sodium Valproate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sodium Valproate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sodium Valproate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sodium Valproate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sodium Valproate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sodium Valproate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sodium Valproate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sodium Valproate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sodium Valproate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sodium Valproate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sodium Valproate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sodium Valproate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sodium Valproate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sodium Valproate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sodium Valproate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sodium Valproate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sodium Valproate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sodium Valproate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sodium Valproate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sodium Valproate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sodium Valproate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sodium Valproate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sodium Valproate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sodium Valproate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Sodium Valproate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Sodium Valproate Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Fresenius Kabi
  8. 8.2.1 Fresenius Kabi Company Information
  9. 8.2.2 Fresenius Kabi Business Overview
  10. 8.2.3 Fresenius Kabi Sodium Valproate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius Kabi Sodium Valproate Product Portfolio
  12. 8.2.5 Fresenius Kabi Recent Developments
  13. 8.3 AbbVie
  14. 8.3.1 AbbVie Company Information
  15. 8.3.2 AbbVie Business Overview
  16. 8.3.3 AbbVie Sodium Valproate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AbbVie Sodium Valproate Product Portfolio
  18. 8.3.5 AbbVie Recent Developments
  19. 8.4 Zentiva
  20. 8.4.1 Zentiva Company Information
  21. 8.4.2 Zentiva Business Overview
  22. 8.4.3 Zentiva Sodium Valproate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zentiva Sodium Valproate Product Portfolio
  24. 8.4.5 Zentiva Recent Developments
  25. 8.5 Wockhardt
  26. 8.5.1 Wockhardt Company Information
  27. 8.5.2 Wockhardt Business Overview
  28. 8.5.3 Wockhardt Sodium Valproate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wockhardt Sodium Valproate Product Portfolio
  30. 8.5.5 Wockhardt Recent Developments
  31. 8.6 Hikma Farmaceutica
  32. 8.6.1 Hikma Farmaceutica Company Information
  33. 8.6.2 Hikma Farmaceutica Business Overview
  34. 8.6.3 Hikma Farmaceutica Sodium Valproate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hikma Farmaceutica Sodium Valproate Product Portfolio
  36. 8.6.5 Hikma Farmaceutica Recent Developments
  37. 8.7 Desitin Pharmaceuticals
  38. 8.7.1 Desitin Pharmaceuticals Company Information
  39. 8.7.2 Desitin Pharmaceuticals Business Overview
  40. 8.7.3 Desitin Pharmaceuticals Sodium Valproate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Desitin Pharmaceuticals Sodium Valproate Product Portfolio
  42. 8.7.5 Desitin Pharmaceuticals Recent Developments
  43. 8.8 Athenex
  44. 8.8.1 Athenex Company Information
  45. 8.8.2 Athenex Business Overview
  46. 8.8.3 Athenex Sodium Valproate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Athenex Sodium Valproate Product Portfolio
  48. 8.8.5 Athenex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sodium Valproate Value Chain Analysis
  2. 9.1.1 Sodium Valproate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sodium Valproate Sales Mode & Process
  6. 9.2 Sodium Valproate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sodium Valproate Distributors
  9. 9.2.3 Sodium Valproate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst